Evidence map›Paper›PMID 34205964›Full record

ArticleCancers2021

Whole Exome Sequencing of Biliary Tubulopapillary Neoplasms Reveals Common Mutations in Chromatin Remodeling Genes.

Claudia Gross, Thomas Engleitner, Sebastian Lange, Julia Weber, Moritz Jesinghaus, Björn Konukiewitz, Alexander Muckenhuber, Katja Steiger, Nicole Pfarr, Benjamin Goeppert and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Claudia GrossInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.ORCID 0000-0002-8996-4185
Thomas EngleitnerInstitute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technische Universität München, 81675 Munich, Germany.
Sebastian LangeInstitute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technische Universität München, 81675 Munich, Germany.ORCID 0000-0003-0406-1401
Julia WeberInstitute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technische Universität München, 81675 Munich, Germany.
Moritz JesinghausInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Björn KonukiewitzInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Alexander MuckenhuberInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Katja SteigerInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.ORCID 0000-0002-7269-5433
Nicole PfarrInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Benjamin GoeppertInstitute of Pathology, University of Heidelberg, 69120 Heidelberg, Germany.
Gisela KellerInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Wilko WeichertInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Nazmi Volkan AdsayDepartment of Pathology, School of Medicine, Koc University, Istanbul 34010, Turkey.
Günter KlöppelInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Roland RadInstitute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technische Universität München, 81675 Munich, Germany.
Irene EspositoInstitute of Pathology, University Hospital of Duesseldorf, 40225 Duesseldorf, Germany.ORCID 0000-0002-0554-2402
Anna Melissa SchlitterInstitute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Technical University of Munich · DEDeutschen Konsortium für Translationale Krebsforschung · DEDüsseldorf University Hospital · DEGerman Cancer Research Center · DEHeidelberg University · DEKoç University · TRTUM Klinikum · DE

Funding

German cancer Research Foundation DFG 284318716
6 · The paper itself

Abstract

The molecular carcinogenesis of intraductal tubulopapillary neoplasms (ITPN), recently described as rare neoplasms in the pancreato-biliary tract with a favorable prognosis despite a high incidence of associated pancreato-biliary adenocarcinoma, is still poorly understood. To identify driver genes, chromosomal gains and losses, mutational signatures, key signaling pathways, and potential therapeutic targets, the molecular profile of 11 biliary and 6 pancreatic ITPNs, associated with invasive adenocarcinoma in 14/17 cases, are studied by whole exome sequencing (WES). The WES of 17 ITPNs reveals common copy number variants (CNVs) broadly distributed across the genome, with recurrent chromosomal deletions primarily in 1p36 and 9p21 affecting the tumor suppressors

Indexed as

bile ductchromatin remodeling genesintraductal tubulopapillary neoplasmspancreaswhole exome sequencing

Identifiers

PMID34205964
PMCPMC8198366
OpenAlexW3167783319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.